On Aug. 18, 2016, BD (Becton, Dickinson and Company) celebrated the 60th anniversary of its manufacturing facility in Sandy, Utah, and announced a $20 million investment in the Sandy site as part of its broader plan to invest in manufacturing capacity and support anticipated growth in the catheter solutions platform.

The site traces its roots to Deseret Pharmaceutical, which started in Murray, Utah in 1956. US acquired the facility in Sandy in 1986, which has grown to 550,000 sq. ft. and employs more than 1,200 associates.

BD products manufactured in Sandy include intravenous (IV) catheters and valves, blood collection devices and surgical products. The site is responsible for more than 200 global patents related to IV catheters. Products manufactured in Sandy are sold in 96 countries worldwide. Associates at the BD facility in Sandy have an average tenure of 13 years.